GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » 3-Year Dividend Growth Rate

Jafron Biomedical Co (SZSE:300529) 3-Year Dividend Growth Rate : 12.20% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co 3-Year Dividend Growth Rate?

Jafron Biomedical Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

The historical rank and industry rank for Jafron Biomedical Co's 3-Year Dividend Growth Rate or its related term are showing as below:

SZSE:300529' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 12.2   Med: 47.4   Max: 65.3
Current: 12.2

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Jafron Biomedical Co was 65.30% per year. The lowest was 12.20% per year. And the median was 47.40% per year.

SZSE:300529's 3-Year Dividend Growth Rate is ranked better than
51.35% of 185 companies
in the Medical Devices & Instruments industry
Industry Median: 11.9 vs SZSE:300529: 12.20

During the past 12 months, Jafron Biomedical Co's average Dividends Per Share Growth Rate was -25.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 12.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 32.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Jafron Biomedical Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Jafron Biomedical Co's Dividend Yield % is 2.39%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Jafron Biomedical Co Ltd is 1.01, which seems too high.

Warning Sign:

Jafron Biomedical Co Ltd stock dividend yield is close to 1-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Jafron Biomedical Co's 3-Year Dividend Growth Rate

For the Medical Devices subindustry, Jafron Biomedical Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jafron Biomedical Co's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jafron Biomedical Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Jafron Biomedical Co's 3-Year Dividend Growth Rate falls into.



Jafron Biomedical Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Jafron Biomedical Co  (SZSE:300529) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Jafron Biomedical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.348
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Jafron Biomedical Co was 1.24. The lowest was 0.34. And the median was 0.47.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Jafron Biomedical Co Ltd is 1.01, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Jafron Biomedical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.6700002023-05-312023-05-302023-05-31Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Jafron Biomedical Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.67/28.05
=2.39 %

Current Share Price is ¥28.05.
Jafron Biomedical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.67.

During the past 13 years, the highest Dividend Yield of Jafron Biomedical Co was 3.94%. The lowest was 0.41%. And the median was 0.82%.

Warning Sign:

Jafron Biomedical Co Ltd stock dividend yield is close to 1-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jafron Biomedical Co 3-Year Dividend Growth Rate Related Terms>


Jafron Biomedical Co (SZSE:300529) Business Description

Traded in Other Exchanges
N/A
Address
No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085
Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.
Executives
Li Feng Director
He Xiao Lian Executives
Dong Fan Directors, Directors, and Executives
Ceng Kai Directors, executives
Tang Xian Min Directors, executives
Zhang Ming Yuan Secretary Dong
Fang Li Hua Supervisors
Zhang Guang Hai Directors, executives
Li De Zhi Executives
Lu Shao Zhang Executives

Jafron Biomedical Co (SZSE:300529) Headlines

No Headlines